Agoracom Blog Home

Posts Tagged ‘tsx-v’

This #Edtech Unicorn Turned Profitable After Tripling Its Revenue in FY19 – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 10:42 AM on Friday, December 20th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

This Edtech Unicorn Turned Profitable After Tripling Its Revenue in FY19

  • Online education market is expected to grow to $1.96 billion by 2021
  • 52 per cent compounded annual growth from 2016, according to a 2017 report published by Google and research firm KPMG

By: Shreya Ganguly

Increased Internet penetration and availability of smartphones has made its way into making the world smaller. Technology is also disrupting the education market where the former is leveraged to make learning more engaging and reach students at places with poor schooling infrastructure. One of the giants in this space, BYJU’s turned profitable and recorded a revenue of INR 1,341 crore for the fiscal year which ended on March 31, 2019. This is thrice the amount of INR 490 crore in FY18.

According to the edtech Unicorn, deeper penetration of its services across India and increase in numbers of paid subscribers are the primary drivers of growth.

“We have exceeded our financial goals that we set at the beginning of the year. Expanding our base across smaller towns and cities and introducing new products have been pivotal to our growth. With 60 per cent of our students based outside the metros, the aspiration and need for quality learning has never been higher,” said Mrinal Mohit, chief operating officer, BYJU’s. 

BYJU’s Growth In Numbers

According to the company, it recorded a net profit of  INR 20 crores in FY 18-19. Its gross revenues also increased to INR 1480 crores from INR 520 crores, last fiscal.  

BYJU’s claims to have over 40 million registered users and 2.8 million paid subscribers currently. According to the company, the average number of minutes a student spends on the app has increased from 64 minutes to 71 minutes per day over the last 12 months and the annual renewal rates are as high as 85%. 

“This year, we also launched our product for young learners (Grades 1-3), which completed our learning offerings from grades 1 – 12.  We are also planning to reach out to deeper parts of India by launching programs in vernacular languages. We strongly believe that we have the capability to create a global product that can revolutionize learning for students across the world,” Mohit said. 

Future Plans

The company is now aimed at doubling its revenue to INR 3,000 crore for the current financial year. Apart from this, Mohit also revealed that the company will also soon launch BYJU’s online tutoring which will further accelerate growth and profitability for the current fiscal.

Edtech Market in India

The online education market is expected to grow to $1.96 billion by 2021, a 52 per cent compounded annual growth from 2016, according to a 2017 report published by Google and research firm KPMG.

Online disruption in the education market takes the classroom directly inside the homes of the students thereby getting wider reach. Apart from this, technological development is making education a more interactive experience for children, thereby increasing their engagement rather than one-way classroom lectures. Also, online lectures allow one-on-one attention to students to help them grow at their own pace.

Currently, apart from BYJU’s notable players such as Unacademy, Toppr, Safeducate and GradeUp are looking to disrupt the edtech market.

Source: https://www.entrepreneur.com/article/344017

The Future of Nickel: Tensions, Trade Bans and Technology – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 5:22 PM on Thursday, December 19th, 2019

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including a 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

The future of nickel: tensions, trade bans and technology

  • It’s an interesting time for nickel on the global markets
  • Prices have risen dramatically despite trade tensions between the US and China, and are expected to explode as Indonesia and the Philippines prepare for nickel export bans

By Umar Ali

Indonesia’s export ban

With increased demand for stainless steel production and recent developments in technologies such as electric vehicles, demand for nickel is higher than ever. Unfortunately, this demand is struggling against an increasingly tightening supply of the essential metal.

In response to the risk of this increasing demand tightening local supply, the Indonesian government announced in September 2019 a ban on the export of raw nickel ores, bringing the ban forward from 2022 to January 2020.

According to GlobalData analyst David Kurtz, this ban is intended to produce value-added nickel products, stimulate domestic processing of ore, and make the country a hub for electric vehicle production.

Indonesia is the largest global producer of nickel and a major supplier of the metal to China’s stainless steel industry; in anticipation of the ban, Chinese producers are building up nickel inventories.

This has increased the price of nickel significantly, with prices at the end of September 2019 reaching more than $16,000 per tonne, an increase of more than 60% from January. When the ban was announced, nickel prices increased by 8.8% to reach a peak of $18,620 per tonne, the highest price since 2014.

While over half of Indonesia’s nickel is processed in the country, around 218,000 tonnes of the metal is unprocessed and would be affected by the ban, which represents around 10% of global demand.

Concerns over supply have led to LME nickel warehouse stock levels dropping by almost 50% since the announcement of the ban, with Reuters reporting that stocks have fallen to 79,800 tonnes, the lowest since January 2009, as of 24 October 2019.

Potential for the Philippines?

The mining sector in the Philippines is expected to benefit from the supply gap created by this export ban, with the country’s nickel industry having suffered in recent years.

As the second-largest producer of nickel, the Philippines accounted for nearly 16% of global production in 2018.

However, production volumes fell sharply in 2016 when the country’s Department of Environment and Natural Resources launched an audit process for over 40 metallic mines, resulting in a number of suspensions and 27 closures. Of these 27 mines, 19 were involved in nickel production, resulting in a drop in nickel production of over 100kt.

Since the shutdowns, output has steadily increased but has become dependent on a smaller number of operations, particularly in the mining region of Caraga. According to Kurtz, the ban in Indonesia “paves the way for higher exports of nickel from the Philippines to China.”

However the shutdowns in the Philippines, as well as the lower quality of nickel ore in the Philippines compared to Indonesia, are expected to challenge this financial growth. The lower grade of nickel ore in the Philippines is a particular problem for Chinese operators, as it affects the ability of nickel pig iron producers to achieve the necessary purity mix for stainless steel production.

With China being a significant importer of nickel, particularly for its stainless steel production, the ongoing trade dispute between the US and China has had a considerable influence on nickel prices.

Prior to the announcement of Indonesia’s export ban, nickel prices fell steeply in the second half of 2018, but has eased in anticipation of trade talks later in 2019. Indonesia’s export ban has also allowed the price of nickel to fare better than other metals such as copper, avoiding the longer-term financial concerns seen across the resources sector.

Future prospects

Primary nickel production is forecast to rise by 9-10% in 2019 to reach 2.4MT, primarily driven by an increase in Indonesia from rising production in new mines. Demand for nickel in China is expected to grow over 2.1Mt, as opposed to the 1.6Mt estimated for 2019.

According to analytics from GlobalData, the number of electric vehicles is expected to increase from 1.6 million in 2018 to 6.8 million in 2023, and the demand for nickel for lithium-ion batteries is expected to quadruple over this period from 3-4% in 2019.

With the export bans in place, nickel prices are expected to remain high while stocks remain low. However, any escalation of the trade tensions between the US and China could lead to a fall in prices, and there remains the possibility of Indonesia relaxing their export ban (as it did previously in 2017 for a ban established in 2014).

This reversal applied to operators working on building processing capacity, and came about due to losses incurred by stated-owned nickel exporter PT Aneka Tambang as well as a need to ease the country’s budget deficit.

Source: https://www.mining-technology.com/features/the-future-of-nickel-tensions-trade-bans-and-technology/

ThreeD Capital Inc. $IDK.ca – #Gaming Is Key to the Mass Adoption of #Crypto #Bitcoin #Ethereum $HIVE.ca $BLOC.ca $CODE.ca

Posted by AGORACOM-JC at 4:29 PM on Thursday, December 19th, 2019

SPONSOR: ThreeD Capital Inc. (IDK:CSE) Led by legendary financier, Sheldon Inwentash, ThreeD is a Canadian-based venture capital firm that only invests in best of breed small-cap companies which are both defensible and mass scalable. More than just lip service, Inwentash has financed many of Canada’s biggest small-cap exits. Click Here For More Information.

Gaming Is Key to the Mass Adoption of Crypto

  • A whole new exciting world of value is being coded into life right now by gamers
  • While it may be a far cry from the lofty ideals of banking the unbanked and taking down the global banking system, gaming is gearing up to be a massive force in the crypto space

By Lark Davis

A whole new exciting world of value is being coded into life right now by gamers. While it may be a far cry from the lofty ideals of banking the unbanked and taking down the global banking system, gaming is gearing up to be a massive force in the crypto space.

Addictively fun games will draw a whole new base of users into the crypto economy. Gamers are an excellent target market for adoption because many gamers are a touch more tech savvy than the average internet user and tend to be a bit more open to new ideas.

Just imagine this — a gamer beating a monster, picking up a rare item, selling that item for Ether (ETH) on a secondary market, and then using that Ether to buy a new hat online. This creates a whole new network of value that is liquid, fast and global — and most importantly, taps into gamers’ existing behavior: playing games.

But for this exciting future to transpire, games need to be fun… addictively fun. Up until now, most crypto games have been little more than retro 1980s throwbacks — with very simple graphics and limited playability — which is nice for nostalgia but will not add anything significant to the crypto economy. However, a new class of games is changing this scenario and is set to take crypto games into the leagues of the truly great online games.

NFTs pave the way

Before looking at some examples, it is important to note that all of this has been enabled by nonfungible token technology, which allows for the proliferation of in-game digital assets on public blockchains.

Gaming could possibly be one of the major contributors to the crypto economy, with game developers making new token standards and technical developments that benefit the entire ecosystem — as well as the players of these games generating significant on-chain activity that helps to feed the miners. So, let us not make the mistake of thinking that crypto games are not lifting their weight in terms of ecosystem development.

Here are a couple of examples of what is being built and played.

Gods Unchained is bringing the wonder and excitement of a collectible card game like Magic: The Gathering to Ethereum. Gods Unchained is graphically enticing and has a great in-game flow of animations that keep the action rolling. The game has already attracted thousands of players to tournaments and continues to find a growing community of enthusiasts. Under the hood, players own the cards that they play with, storing the unique nonfungible tokens in their Ethereum wallet. Rarity is provable on-chain, and swaps on the secondary market are seamless. In February, a card sold for $62,000, which is astonishing for such a new game and really underlines the excitement building around crypto games.

Related: Blizzard Bans Hearthstone Player, Blockchain Comes to Rescue

Then, there is the Enjinverse, which is a growing multi-game experience that allows for in-game items to be used and moved seamlessly between dozens of games. Enjin itself is one of the most important cryptocurrencies in the gaming realm. One of the most interesting games in the Enjinverse is Age of Rust, which is a post-apocalyptic sci-fi adventure with stunning graphics and an enticing story. Looking at the popularity of games like Dead Space or Fallout, it becomes clear that Age of Rust stands a good chance of gaining significant popularity.

While the game itself is exciting, it is the underlying tech that really makes Age of Rust stand out: Not only are Enjin assets interoperable between games, but they also have value baked into them. So, regardless of the long-term outcome of the game itself, the items you acquire in the game all are forged with Enjin tokens melted into the in-game asset. These assets can be melted back down at any time, enabling you to claim the tokens underpinning the value of the item — as well as creating increased scarcity for the item class, as once it is melted, that item it gone forever.

Here are some major players to watch. Enjin is working closely with Unity, which accounts for nearly half of all game developers globally. Cocos has 1.4 million game developers using its engine, and the launch of its blockchain is likely to bring many of those developers over. Loom is focused on interchain operability and on enabling fun, user-facing games that will draw more users into crypto — with such titles as Neon District, which is a Blade Runner-esque RPG.

According to the recent research conducted by a gaming and e-sport analytics provider, the gaming industry as a whole is expected to be worth $180 billion by 2021, so the opportunity for crypto gaming is massive. For players, there will be better experiences; for developers, there will be more tools to attract players to their games; and for investors, there will be the ability to own the cryptos that will be at the forefront of a major trend — but that has not yet taken off.

Source: https://cointelegraph.com/news/gaming-is-key-to-the-mass-adoption-of-crypto

CardioComm Solutions $EKG.ca – What’s App? – End of Year Round-up on #Mhealth App Developments $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 3:52 PM on Thursday, December 19th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

What’s App? – End of Year Round-up on mHealth App Developments

  • Advantages of mHealth apps include streamlining the exchange of health information and a better user experience
  • From a data perspective, apps can use big data to analyse unstructured data and identify patterns and environmental factors that will improve patient treatment

Mason Hayes & Curran

An Irish Times special report estimates that over seven million patients worldwide are actively using digital health apps as part of their care plan. The availability of remote and mobile healthcare solutions relating to fitness, wellbeing, health and medical treatment could be life-changing for those living in countries lacking easy access to medical care.

Advantages of mHealth apps include streamlining the exchange of health information and a better user experience. From a data perspective, apps can use big data to analyse unstructured data and identify patterns and environmental factors that will improve patient treatment.

Government adoption

With this in mind, many governments are encouraging the uptake of mHealth apps.

In the UK, the NHS website has a digital library showcasing mHealth apps. It lists mHealth apps that have been deemed as clinically safe. The functionality of the apps is varied and provides services like repeat prescriptions services, speech and language therapy, and instant access to medical records. Patients can even use certain apps to monitor their conditions such as diabetes.

The HSE in Ireland is following the lead of the NHS. It is working with Orcha, a company that reviews health apps, to provide an Irish eHealth app library that lists apps reviewed by Orcha.

Orcha assesses mHealth apps’ data use policies and compliance with relevant standards. It rates the app out of a maximum score of 100, with a lower score indicating that there may be issues that the user should investigate before using the app. Clinical assurance and user experience are also rated to help users and clinicians compare mHealth apps.

The Irish eHealth app library to date lists over 700 mHealth apps. The HSE points out that the library is a tool for users to identify and compare apps themselves but it is not intended to promote or recommend any particular app.

Other developments

Other recent developments in the mHealth sector include:

  • A WhatsApp style messaging app developed by junior doctors that the developers claim could save the NHS £44m a year. The app helps NHS workers exchange patient information, make clinical decisions, manages their workload in a legally compliant forum and removes the need for pagers. Currently more than 100 NHS hospitals and care commissioning groups in the UK are using the app.
  • An app that monitors children’s temperature. It uses a patch to wirelessly monitor the baby’s temperature and sends alerts to smartphones. Unlike a typical thermometer, children do not have to be woken from their sleep to obtain temperature readings.
  • Tablets with micro ingestible sensors embedded in the pills that can alert smartphones when the pills touch the stomach lining of patients. The developers believe this could be useful for the treatment of mental illnesses if medication compliance is proving difficult. It could also be an invaluable tool for pharmaceutical companies or medical institutions to record timings of ingestion of medications during clinical trials.
  • A device and accompanying app that takes ECG recordings via electrodes. The AI system of the software performs an automatic analysis and informs the patient of their heart rhythm. This data can then be sent directly to the patient’s clinician for further analysis and consultation. The product has already launched in the UK.
  • A skin mapping app that incorporates AI technology. The app is designed to detect new moles or marks on the skin. These are one of the most common warning signs of melanoma and early detection can improve the success rate of treatment.
  • Adia Health provides at-home finger prick fertility blood tests, a preconception plan to help improve fertility health and access to fertility specialists remotely.

At a broader level, technologies like blockchain, the Internet of Things and AI / augmented reality are taking mHealth to the next level.

Despite this, the technological advancement and wider adoption of mHealth apps brings important legal responsibilities. From a medical standpoint, mHealth apps can be very useful, but they can never replace the advice of someone’s own clinician.

Regulatory considerations

Depending on their functionality, some mobile apps and standalone software may fall within the definition of a ‘software medical device’. Any mHealth app deemed to be a software medical device will be subject to onerous obligations regarding safety, compliance and post market surveillance.

You can read more about the compliance and liability aspects of mHealth apps and upcoming changes to the law in our recent articles: ‘When is a Health and Fitness App not just an App? and Diagnosis on Demand: Potential of Healthcare Apps.

Health data and data protection

Earlier this year, the British Medical Journal warned that popular mHealth apps may not be keeping personal data about medical conditions confidential and users may not be aware of how the data they provide on these apps is being shared.

In Ireland, mHealth apps must comply with laws like the General Data Protection Regulation (GDPR) and the Irish Data Protection Acts 1988 – 2018. The Data Protection Acts transpose into Irish law the EU’s Law Enforcement Directive and adopt specific rules to regulate the processing of personal data for the purposes of health research.

At a basic level, mHealth apps that process personal data revealing information about an individual’s health will attract more stringent data protection obligations as this data is ‘special category data’ under data protection law. Processing any special category data is only allowed in the limited circumstances set out in Article 9 of the GDPR.

As the vast majority of mHealth apps are designed to operate online they are vulnerable to cyber-security threats. The GDPR make it essential for a data controller to adopt robust security practices for personal data, which may include pseudonymising or encrypting it.

Code of Conduct on privacy for mHealth apps

The Code of Conduct on privacy for mHealth apps aims to regulate and secure the personal data gathered by mHealth apps and promote trust among users. The Code has not yet been approved and the European Commission is working with industry stakeholders to encourage the further development of the current draft Code.

What the future holds

There have been many new developments in 2019 in the mHealth app sector. It is reassuring that governments are encouraging more widespread adoption of digital healthcare solutions by healthcare

practitioners and individuals. However, if mHealth apps are to truly flourish, individuals must trust the mHealth industry and how it is regulated.

Many mHealth apps have access to vast amounts of sensitive health information. There are important data protection implications if special category data relating to individual’s health is collected and processed. Given the increased privacy and security risks, tech companies and app developers must be aware of the data protection laws and ensure they are complying with them. From a transparency perspective, they should also ensure users are aware of how the data they provide on mHealth apps is being shared.

From a regulatory point of view, it would be prudent for tech companies and app developers to determine if an app is a software medical device. If so, they should ensure they are meeting their obligations regarding safety, compliance and post market surveillance and keep up to date with regulatory changes due to take effect next year.

We also hope 2020 brings progress in finalising the draft Code of Conduct on privacy for mHealth apps that will set out practical guidance for app developers on data protection principles when developing mHealth apps.

Source: https://www.lexology.com/library/detail.aspx?g=3f0c2427-242b-4299-81d9-bff80740161c

Indian #EdTech Unicorn Byju’s Lands $540M to Expand Globally – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 12:29 PM on Thursday, December 19th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Indian EdTech Unicorn Byju’s Lands $540M to Expand Globally

  • Indian Edtech firm Byju’s has raised $540 million in funding round led by South Africa’s Naspers Ventures and the CPP Investment Board, the Canada Pension Plan Investment Board.
  • With this investment, it is aiming to become the world’s most valuable education technology business.

by StartupWorld Staff         

Before one year ago, Byju’s revenue expanded to $208 million from $73.2 million. Earlier this year, the Bangalore headquartered startup valued to $5.75 billion in its preceding financing round. By March 31, 2020, it is going to double its income to $422 million. With this new investment, Byju’s will come in the ranking top valuable startups in India like Paytm, Oyo, and Ola.

Founded in 2011 by Byju Raveendran, Byju’s has become quite popular among students in India. It mainly focuses on maths and science subjects and around 35 million students in India are using the app. It has app felicitating Indian regional languages, and it is also aiming to launch its new version app for English speaking students in other countries in 2019.

Byju’s had reported a net loss of $4 million on revenue in the last fiscal year. However, this financial year is very profitable for the company including taxes and all other expenses in its net profit.

Byju’s simplifies the process of learning complex subjects to students through its app. The tutors explain tough theories and calculations through day-to-day experiences. Currently, it has 2.8 million paying subscribers and 40 million registered students globally. The app helps students who are pursuing undergraduate and graduate courses. Besides,  it is gaining more popularity in small towns in India.

Chief operating officer of Byju’s Mrinal Mohit said that the startup is going to analyze more new products along with ‘Online Tutoring’ to expand its growth and get more profits in the coming year.

As part of the global expansion, the startup is planning to enter some of the countries such as the US, UK, Australia, and New Zealand. This year, it acquired Osmo, a Palo-Alto based education startup for $120 million. Osmo is popular among 5 to 12 age group children in the US.

Source: https://www.startupworld.com/news/byjus-land-540m-dollars-expand/

Empower Clinics $CBDT.ca Completes Agreement With Heritage Cannabis Subsidiary Endocanna Health $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 11:47 AM on Thursday, December 19th, 2019
  • Signed an agreement with Endocanna, to licence and distribute Endo.dna test kits through its network of clinics and market directly to the Company’s 165,000 patient database, and as a standard offering in the Sun Valley Health franchise program
  • Company plans to partner with Endocanna for their Endo.Aligned Formulations program to create, manufacture, produce and distribute specialized CBD based products utilizing the Company-Heritage joint venture extraction centre in Sandy, OR.

VANCOUVER, BC / December 19, 2019 / Endocanna Health Inc. (“Endocanna“), a research and development biotechnology company specializing in endocannabinioid DNA testing, and a partly owned subsidiary of Heritage Cannabis Holdings Corp. (CSE:CANN) (“Heritage“) partners with Empower Clinics to distribute Endo.dna test kits and develop Endo.Aligned product formulations.

EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, is pleased to announce it has signed an agreement with Endocanna, to licence and distribute Endo.dna test kits through its network of clinics and market directly to the Company’s 165,000 patient database, and as a standard offering in the Sun Valley Health franchise program.

In addition, the Company plans to partner with Endocanna for their Endo.Aligned Formulations program to create, manufacture, produce and distribute specialized CBD based products utilizing the Company-Heritage joint venture extraction centre in Sandy, OR.

“Empower with its clinic network, large patient base and numerous physicians are an ideal distribution partner for Endocanna,” said Steven McAuley, Empower’s Chairman and CEO. “As we strive to be a leader in patient care and efficacy, having deeper insights about our patients unique DNA profile allows our physicians to provide even more effective cannabis based treatment options. Then, translating that knowledge into new product formulations with Endocanna, will greatly enhance the long-term shareholder value we are creating.”

“We are pleased to collaborate with a life sciences company like Empower to develop a custom endocannabinoid-based therapeutic efficacy model,” says Len May, Endocanna Health CEO and founder. “Our goal at Endocanna Health is to identify and optimize cannabinoid-based therapies based on an individual’s DNA while mitigating potential adverse-events and drug interactions. The data will support DNA validation along with peer-to-peer efficacy feedback, and provides key data to support our mission in facilitating the highest quality, consistent, personalized, endo-aligned cannabinoid products.”

The Endo·dna test analyzes specific DNA markers to provide a personalized report, Endo·Decoded, that can help guide decisions for choosing the right cannabinoid products with the right:

  • Formulation – full-spectrum or broad-spectrum
  • Dose – the amount you take and when you take it
  • Delivery – flower, aerosol, vaping, sublingual (under the tongue), topical, or edible

The Endo·Decoded report helps consumers uncover optimal cannabinoid ratios and terpene profiles for their specific genetic makeup. Endocanna’s customized endocannabinoid genomics super-chip and algorithm provides consumers with:

  • Ideal cannabinoid ratios and terpene profiles, methods of delivery or consumption, and dosing.
  • Suggestions for specific terpenes and cannabinoids to seek out or to avoid.
  • Individualized risks or benefits from using cannabinoids.
  • Suggestions commercially available products and brands most aligned with individual genetics and formulations suggestions.

ABOUT EMPOWER CLINICS INC.

Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative uses of medical cannabis. It is expected that Empower’s proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based product options in its clinics, online and at major retailers. With over 165,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirement’s in 2019 and beyond.

ABOUT ENDOCANNA HEALTH INC.

Endocanna is a biotechnology research company that utilizes a patent-pending process for its cannabinoid DNA variant report, Endo·Decoded™ and product- matching algorithm, Endo·Aligned™. Endo·dna™ provides two ways to submit DNA for analysis, either collected through a simple saliva swab or a direct upload of genetic data files from popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or MyHeritageDNA. Endocanna’s HIPAA compliant and secure health and wellness portal, Mydna.live, provides customers with a personalized experience where they can access their Endo·Decoded report and Endo·Aligned formulation suggestions for their specific genotype. In 2019, cannabis producer Heritage Cannabis Holdings (CSE:CANN)(OTC:HERTF) acquired a 30 percent stake in Endocanna Health Inc.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steve Low
Boom Capital Markets
[email protected]
647-620-5101

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: endocanna agreement; the Company’s intention to open a hemp-based CBD extraction facility; the expected product development and manufacturing; the expected benefits to the Company and its shareholders as a result of the proposed JV. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that: Heritage and Empower may be unable to agree on terms of a definitive agreement with respect to the JV; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed JV or extraction facility; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE: Endocanna Health Inc.

VIDEO: Lomiko Metals $LMR.ca Is Well Positioned To Supply #Graphite to North American Giga Factories $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM-JC at 9:31 AM on Thursday, December 19th, 2019

As 2019 comes to a close, sit back and watch CEO Paul Gill provide a compelling year-end recap. With a high grade graphite resource already in place, growing and situated in North America, Lomiko Metals (LMR:TSXV) believes it is on the verge of becoming a supplier to multiple gigafactories being built in North America to support the electric vehicle boom.

CardioComm Solutions $EKG.ca – Remote Patient Monitoring, Reimbursement Topped Headlines in 2019 #Mhealth $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:39 PM on Wednesday, December 18th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Remote Patient Monitoring, Reimbursement Topped Headlines in 2019

Top mHealth trends in 2019 included remote patient monitoring, telehealth reimbursement, substance use disorder care, chronic disease management, and direct-to-consumer mHealth technology.

  • Based on our most clicked stories in 2019, those trends included remote patient monitoring, telehealth reimbursement and coding, behavioral health/substance use disorder care, chronic disease management strategies, and direct-to-consumer mHealth technologies.

By Samantha McGrail

As 2019 comes to an end, healthcare organizations are reflecting on the trends and stories that most influenced their behaviors in the past year. Based on our most clicked stories in 2019, those trends included remote patient monitoring, telehealth reimbursement and coding, behavioral health/substance use disorder care, chronic disease management strategies, and direct-to-consumer mHealth technologies.

In the following article, mHealthIntelligence.com will break down these trends, as well as the strategies and best practices industry leaders developed in response. 

Remote patient monitoring

In 2019, healthcare organizations looked to invest in remote patient monitoring (RPM) solutions to transition to value-based care. Many healthcare leaders expected these solutions to support high-risk chronically ill patients whose conditions are considered unstable and at a risk for hospital admission. 

Specifically, 88 percent of providers who were surveyed by health IT thought leaders earlier this year had invested or were evaluating investments in RPM technologies. 

RPM solutions have been proven to be clinically effective as an early symptom management tool for chronically ill patients, who represented about 45 percent of the US population according to the survey. These solutions allowed risk-bearing organizations to remotely monitor patients with chronic conditions to help control healthcare costs, improve care quality, and increase access to care for patients in underserved areas. 

In addition, these solutions helped manage value-based risk associated with large patient populations with chronic conditions. 

“The ability of the device to simultaneously record multiple variables such as heart rate and accelerometer data allowed us to more accurately determine the patient’s state, whether he/ she is active, sedentary, asleep, or not currently using the device,” the researchers reported.

Because remote patient monitoring is becoming more widespread, more healthcare organizations are implementing RPM into their health systems. Recently, Humana announced a partnership with Philips Health to launch a remote member monitoring pilot for certain Medicare Advantage members with severe congestive heart failure (CHF).

“Our goal is to continue to find ways to help our Medicare Advantage members stay longer and safer in their homes,” Susan Diamond, president of Humana’s Home Business segment, said in a press release.

Telehealth reimbursement and coding

Along with remote patient monitoring, telehealth has been extremely vital for healthcare in 2018 and will continue to play a significant role going into the new year. But healthcare organizations are still waiting on reimbursement and billing policies to catch up to telehealth adoption..

One of the top read stories from 2019 was the American Medical Association’s (AMA) creation of new codes for the use of telehealth and behavior assessment and intervention services. These codes “more accurately reflect current clinical practice that increasingly emphasizes interdisciplinary care coordination and teamwork with physicians in a primary care and specialty setting,” the association stressed. 

The goal for the new codes was to expand pathways for physicians across the US who deal with diverse patients, including those from underserved areas, and those who have any access to care they may need. 

CMS has followed suit, implementing the AMA and its Digital Medicine Payment Advisory Group to include new telehealth codes in the 2018 Medicare physician fee schedule. And in the beginning of this year, CMS released its 2020 physician fee schedule that included numerous additions that will enable more reimbursement for connected health services next year. 

In October of this year, Pennsylvania tried again to pass comprehensive telehealth legislation after the bill was denied last year because of disagreements over payment parity. 

State Senator Elder Vogel introduced The Telemedicine Act (SB 857), which aimed to establish definitions for telemedicine and telehealth, provide temporary evaluation and treatment guidelines for reimbursement, and give state departments up to two years to draft permanent rules and regulations. 

The new bill includes remote patient monitoring technologies, which gives providers the opportunity to use these connected health services. About a dozen states have passed legislation demanding payment parity for telehealth, but most have failed because of strong opposition from healthcare payers. 

Addressing substance abuse using mHealth

An estimated 115 people die each day from opioid abuse, an issue that has become more widespread in the past decade. Healthcare providers have been actively searching for a solution to tackle this issue, and many have found a pathway to success using mHealth and telehealth technology.

Applying MHealth and telehealth technology to addiction treatment is expected to make one of the biggest impacts on substance use disorder care. Connected health platforms allow providers to work with the individual patient anytime they need to, and are able to see what the patient experiences each day. 

“We’re building a panoramic view of your life,” said Jacob Levenson, CEO of MAP Health Management, a Texas-based national network of almost 100 addiction treatment providers. The organization has adopted digital health tools for care management and coordination of substance use disorder patients.

The smartphone is also a great tool for addiction treatment, as it offers both a platform for population health programs and individual treatments. Healthcare providers are able to send out messages offering support or information via text, SMS, or e-mail to large groups at any time. They can also personalize messages for individuals, connecting information to one’s habits, location, or medical record.

MHealth apps are becoming increasingly more popular tools. Apps could feature surveys, messaging or chat rooms, links to resources, messaging with care providers or a substance abuse specialist, and a 911 link for immediate help. 

“Medical devices, including digital health devices like mobile medical apps, have the potential to play a unique and important role in tackling the opioid crisis,” FDA Commissioner Scott Gottlieb, MD, said in a press release featured on the FDA website. “We must advance new ways to find tools to help address the human and financial toll of opioid addiction.” 

Chronic disease management strategies

While MHealth platforms were important for addressing the opioid crisis, the solutions have also been useful for chronic disease management. A growing number of Americans are suffering from more than one chronic condition, prompting more healthcare providers to take the appropriate measures to tackle this issue in 2019.

For example, in January, Omada Health, a digital therapeutics company that focuses on obesity-related chronic conditions, created a cognitive behavioral therapy program (CBT) for those dealing with depression and anxiety. 

“Depression and anxiety are a known barrier to healthy behaviors including medication adherence, optimal nutrition, and seeking timely preventive care. With the addition of CBT curriculum, we can more fully support our participants as they manage their conditions. And, through our digital platform, we can do it at scale,” Carolyn Bradner Jasik, MD, Omada’s Vice President of Medical Affairs, explained in a press release.

The challenge going into the coming years is developing a digital health platform that is able to integrate different programs and allow for easy access for both patients and providers.

A few weeks ago, a Pennsylvania health system also created a telehealth and remote patient monitoring platform to allow patients living with ALS to receive at home care. Most patients with ALS have to travel hours for meetings with doctors and specialists, which can prove to be challenging. But the telehealth platform allows the meetings to be held at home. 

Heart failure (HF) patients receiving targeted virtual behavior therapy found significant improvements in self-care, a recent study published in the journal Circulation found. The study conducted by Humana and AbleTo found a correlation between improving behavioral health care and co-existing physical conditions. The study also noted improvements in self-care, depression symptoms, and awareness of physician recommendations among patients that received HF-focused virtual behavioral therapy over eight weeks.

Chronic disease management is vital to reduce costs by addressing the patient’s illness or condition with maximum clinical outcomes, while helping beneficiaries control their disease in an effective way. 

Direct-to-consumer mHealth technology

The healthcare industry is facing major disruption from non-traditional companies, like Amazon, Google, and Apple. The mHealth space has been no different according to the top stories from 2019.

In September of this year, Amazon prepared to take on the direct-to-consumer telehealth industry through its new platform, Amazon Care. Amazon Care is a virtual care clinic offering telehealth and mHealth services for its employees in the Seattle area, including on-demand access to a clinician online messaging for healthcare questions, a prescription service, and the option of scheduling an appointment through Seattle-based Oasis Medical. 

Apple Watch can be used by clinicians to detect atrial fibrillation. But will care providers rely on these devices to present them with accurate information?

A survey of 420,000 individuals conducted by researchers at the Stanford University School of Medicine found that over an eight month span, the Apple Watch detected an irregular heart rate in .52 percent of individuals or 2,161 people. And almost three-quarters of the users who were notified about an irregular pulse contacted a care provider for further treatment.

“The study’s findings will help patients and clinicians understand how devices like Apple Watch can play a role in identifying atrial fibrillation, a deadly and often undiagnosed disease,” Mintu Turakhia, MD, an associate professor of cardiovascular medicine, said in the press release. “Additionally, these important findings lay the foundation for further research into the use of emerging wearable technologies in clinical practice and demonstrate the unique potential of large-scale app-based studies.”

In addition, a Gallup survey this month showed that nearly one in five Americans are using an mHealth wearable. Adults younger than 55 are twice as likely to use or have used mHealth. And individuals older than 55 and women, are more interested in using mHealth than men. About half of the women respondents under 55 said they use or have used mHealth in the past. While men over age 55 are the least likely to use or have used the technology.

Jefferson Health recently partnered with Quick’r Care to create a mHealth platform to allow patients to choose their correct care path. Through JeffConnect’s virtual care service. Consumers will have on-demand video access to health system’s care providers.

“This is what people who feel bad need right now, right when they begin to feel sick,” added Stephen K. Klasko, MD, president of Thomas Jefferson University and CEO of Jefferson Health. “Working with Quick’rCare allows us to expand our commitment to healthcare with no address.”

Overall, Apple products are designed to make healthcare more human. Devices are meant to protect patient data and give easy accessibility to everyone who uses Apple products. Patients are able to access medical records and communicate from at home if needed. But providers continue to question whether the information they are receiving is accurate, as with new technologies, there isn’t always this guarantee.

Source: https://mhealthintelligence.com/news/remote-patient-monitoring-reimbursement-topped-headlines-in-2019

#Edtech Firm Springboard Raises $11 Mn From Reach Capital, Others To Expand Operations – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 11:07 AM on Wednesday, December 18th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Edtech Firm Springboard Raises $11 Mn From Reach Capital, Others To Expand Operations

  • Pearson Ventures, IFC, Costanoa Ventures, Learn Capital, and Blue Fog Capital also participated in funding round
  • Springboard will invest funds in expanding operations, adding more courses, hire more employees
  • Springboard has also partnered with US-based tech giant Microsoft

Aman Rawat

San Francisco and Bengaluru-based online edtech startup Springboard has raised $11 Mn in a post-Series-A funding round led by Reach Capital. Venture capital companies such as Pearson Ventures, International Finance Corporation (IFC), as well as its existing investors Costanoa Ventures, Learn Capital, and Blue Fog Capital also participated in the funding round.

With the recently raised funds, Springboard will expand its operations, add more courses, and bring more talent to the company. “We will use this funding to grow our Indian presence with more courses in design and software engineering and continue our expansion into additional geographies,” said Vivek Kumar, Springboard India’s managing director.

Though the current employee strength of the company stands at 130, Springboard plans to increase the headcount to over 200 in the next few quarters.

Springboard has also partnered with US-based tech giant Microsoft to train and provide jobs to 5,000 students in the analytics profession over the next three years through its new Data Analytics Career Track platform, which is co-developed by the tech company.

Further, in this partnership, Microsoft will provide educational content and access to its tools. On the other hand, Springboard will provide mentorship, support and career services.

Founded in 2013 by Gautam Tambay and Parul Gupta, Springboard is a workforce upskilling edtech startup that offers online courses and extensive mentor-based learning for early and mid-level professionals in data science, UX design, digital marketing, and other technology areas. The company has so far raised $20 Mn in funding.

Highlighting the need for upskilling of developers which comes in every three to five years, Kumar said that the company’s industry-designed programmes, combined with in-depth, one-on-one mentorship and career guidance, enable people to achieve their full potential.

The company claims to have enrolled over 14K students for its programmes worldwide. Notably, in 2019, the company has launched three new programmes for tech learners in India. “Springboard plans to grow its Indian presence with more courses in design and software engineering,” Kumar was quoted as saying.

Kumar further claimed that for its skilling courses, the company has so far maintained a 99.9% success rate in job guarantee programmes.

According to a report by Google and KPMG, the edtech market is expected to have a significant impact on the online education sector, which has the potential to touch $1.96 Bn by 2021 from $247 Mn at present.

The Indian education market is vast, complex, and has innumerable existing gaps. So, despite the proliferation of both Indian and foreign edtech companies, there is still enough scope to leverage the upskilling game.

In India, Springboard competes with startups such as Udacity, Coursera, Udemy, and Progate which are also leveraging their online platforms in helping tech employees upskill their skills and remain relevant to the changing times.

Source: https://inc42.com/buzz/springboard-raises-11-mn-from-reach-capital-others-to-expand-operations/

PRIMO Nutraceuticals Inc. $PRMO.ca – Lawmakers pressure #FDA to make clear guidelines on #CBD $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:12 AM on Wednesday, December 18th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Lawmakers pressure FDA to make clear guidelines on CBD

  • With the passing of the 2018 Farm Bill, farmers, manufacturers and consumers are keeping a watchful eye on the agency and how they might address compliance for the thousands of companies selling the product and the millions of consumers vying to use it. 

June 25, 2019, Senator Ron Wyden sent a letter to the Department of Health and Human Services and the Food and Drug  Administration urging both entities to provide clarity around CBD products derived from hemp.

The FDA has been under a magnifying glass since hemp was declassified as a schedule I drug, having formerly fallen under the thumb of the Controlled Substances Act of 1970.

With the passing of the 2018 Farm Bill, farmers, manufacturers and consumers are keeping a watchful eye on the agency and how they might address compliance for the thousands of companies selling the product and the millions of consumers vying to use it. 

Yet silence and lack of clarification on a potential path towards compliance for supplement producers has left many chomping at the bit for the agency to come up with regulatory guidelines for selling Food and dietary supplements containing CBD. In the interim, well-established companies such as Next Green Wave, Inc. (Next Green Wave, NGW:CSE | NXGWF:OTCQX) have continued to solidify their position in the market, ready and able to serve the exponentially growing demand of what promises to be a $20 plus billion-dollar industry.

A Slow and Arduous Process

In Wyden’s letter, the lawmaker criticized the FDA’s indication that it could take up to 3 to 5 years for the FDA to implement final regulations for companies to lawfully sell CBD infused foods, calling the suggestion “unacceptable.” Wyden wrote that he urges the FDA to quickly implement “enforcement discretion guidelines” by August 1, then issue an interim final rule pending a permanent rule so that companies will have clarity on how CBD  in food and dietary products will be regulated. 

This argument may have fallen on attentive ears, but as of the date of this publication, the FDA has yet to provide any clear established guidelines. Although the agency has wielded their powers against a handful of “bad actors”, their approach seems to be that of “wait and see” with regards to due process.

The letter penned by Wyden also stressed the economic impact growers in states like Oregon would benefit from by allowing CBD to be in more products, but are halted until the FDA gives the okay that CBD in ingestible products is lawful to sell and okay to use. 

However, this isn’t the first letter Wyden has sent to the agency regarding a regulatory pathway to CBD commercialization. In January the lawmaker co-authored a letter with Senator Jeff Merkley telling the FDA they must revamp current legislation around offering CBD products. Both senators advised former commissioner Scott Gottlieb to “immediately begin updating regulations for hemp-derived CBD and other hemp-derived cannabinoids, and give U.S. producers more flexibility in the production, consumption, and sale of hemp products,” according to the letter. 

FDA is listening to public demand for clear CBD regulations

The FDA has slowly but surely has been taking measures to develop guidelines around selling CBD ingestible-products. In late May, the agency held a public hearing allowing stakeholders the opportunity to share their reasons why the FDA-regulation for CBD food and dietary products is crucial, according to the Chicago Tribune

The agency also gave a chance for the public to weigh in on CBD regulation by opening a public docket for individuals to add comments. The deadline to submit comments was July 16, and the agency received over 3,000 comments, according to the Chicago Tribune. In conjunction with the open docket, the FDA also published an article July 17 echoing the agency’s stance on CBD and concern for public safety.

“We recognize that there is significant public interest in these products, for therapeutic purposes and otherwise,” the article said. “At the same time, there are many unanswered questions about the science, safety, and quality of many of these products. As we approach these questions, we do so as a science-based regulatory agency committed to our mission of protecting and promoting public health.” 

In the “Listening to and learning from stakeholders” section of the article, the FDA insists that relative questions must be answered in order to develop a clear pathway to regulate CBD products which include the following: 

  • How much CBD is safe to consume in a day? How does it vary depending on what form it’s taken?
  • Are there drug interactions that need to be monitored?
  • What are the impacts on special populations, like children, the elderly, and pregnant or lactating women?
  • What are the risks of long-term exposure?

In a second article published on the same day, the FDA stressed it has not approved any CBD products besides Epidiolex, a drug which treats seizures caused by epilepsy. And is currently working to figure out how CBD will affect body parts, special populations and pets. 

Since both the public hearing and window to submit comments to the FDA have both passed, the agency says it will review submitted information and intends to follow up with its findings “around the end of summer/early fall,” according to the Chicago Tribune. 

It is unclear if the FDA will tentatively meet this deadline, but the agency will most likely continue to be pressured by lawmakers and the public to provide a regulatory framework around the selling and obtaining CBD food and dietary supplements. 

Source: https://t2conline.com/lawmakers-pressure-fda-to-make-clear-guidelines-on-cbd/